Young John Alexander sold $340K of AMBA

Young John Alexander (CFO) sold 5,033 shares of AMBARELLA INC (AMBA) at an average of $67.54 ($66.98–$67.87, $0.34M total) across 2 trades on 2026-06-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Young John Alexander
Published Jun 18, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 11:49 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMBA
Neutral
medium confidence
Mentioned
$AMBA
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBANeutralLow
01

Why it matters

The disclosure confirms the CFO executed two open-market sale trades on 2026-06-17 totaling 5,033 shares at an average price of about $67.54, with holdings after the sale of 112,590 shares.

02

Market read

Traders may monitor insider activity, but 10b5-1 selling typically has limited predictive value for near-term fundamentals.

03

What to watch

The article does not state whether other insiders sold/bought around the same window, nor does it provide context on total insider ownership changes beyond the post-transaction holdings.

Relevance 3/10Novelty 3/10Timing: Filed 2026-06-18, disclosing sales executed 2026-06-17.

Background

This is an SEC Form 4 insider transaction for AMBARELLA, reported by the CFO.

Company-level read

Ticker impact

$AMBANeutralMedium confidence
Context

AMBARELLA CFO Young John Alexander sold about $339,946 of AMBA shares via an open-market sale under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact is likely short-lived.

Evidence & confidence

The filing is a disclosed insider sale with a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No direct sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect liquidity planning rather than bearish fundamentals, so traders may ignore it.

Key entities

  • AMBARELLA INC

    US-listed company whose CFO insider sale is disclosed on Form 4.

  • Young John Alexander

    CFO who sold shares under a pre-arranged Rule 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMBAMed

Ambarella (AMBA) Shares Rise 2.4% Amid Nvidia Acquisition Specul

Ambarella (AMBA) shares rose 2.4% on reports Nvidia (NVDA) may join acquisition talks, alongside NXP (NXPI) and Qualcomm (QCOM). The company's P/S ratio is 6.7x, below historical and industry medians, reflecting market skepticism. Insider activity shows $17.1M in sales over the past year. Ambarella specializes in low-power semiconductor solutions for video and AI applications.

$AMBAHighAI 8/10

Ambarella speculated to have a rival suitor - Betaville

Ambarella (AMBA) may have a second potential buyer, following reports of NXP Semiconductors (NXPI) exploring an acquisition. Traders suggest a bid of 75% cash and 25% shares, valued between $95 and $105 per share, citing a Betaville alert. The identity of the new suitor is unknown.

$AMBAHighAI 9/10

ZEDEDA Deal Targets $30B Edge AI Market

Ambarella and ZEDEDA announced a partnership on September 15, 2026, integrating ZEDEDA's EVE-OS with Ambarella's N1 edge AI chips. The deal targets the $30B edge AI market, with developer kits expected in Q4 2026. Ambarella reported Q2 2026 revenue of $108.1M, up 13.2% YoY, while ZEDEDA has raised over $129M in funding.